Strauss Group Ltd.
Strauss Group Ltd. (SGLJF) Financial Performance & Income Statement Overview
Review Strauss Group Ltd. (SGLJF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Strauss Group Ltd. (SGLJF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Strauss Group Ltd. SGLJF financial performance.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $1.89B | $1.79B | $1.87B | $1.70B |
Cost of Revenue | $1.27B | $1.20B | $1.22B | $1.12B |
Gross Profit | $612.00M | $587.00M | $653.00M | $583.00M |
Gross Profit Ratio | $0.32 | $0.33 | $0.35 | $0.34 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $461.00M | -$811.00M | $487.00M | $473.00M |
Operating Expenses | $431.00M | $35.00M | $437.00M | $445.00M |
Total Costs & Expenses | $1.71B | $1.24B | $1.66B | $1.56B |
Interest Income | $29.00M | -$14.00M | $5.00M | $24.00M |
Interest Expense | $42.00M | $44.00M | $45.00M | $40.00M |
Depreciation & Amortization | $88.00M | $67.00M | $90.00M | $89.00M |
EBITDA | $298.00M | $698.00M | $292.00M | $251.00M |
EBITDA Ratio | $0.16 | $0.39 | $0.16 | $0.15 |
Operating Income | $181.00M | $552.00M | $216.00M | $138.00M |
Operating Income Ratio | $0.10 | $0.31 | $0.12 | $0.08 |
Other Income/Expenses (Net) | -$13.00M | $35.00M | -$59.00M | -$16.00M |
Income Before Tax | $168.00M | $587.00M | $157.00M | $122.00M |
Income Before Tax Ratio | $0.09 | $0.33 | $0.08 | $0.07 |
Income Tax Expense | $57.00M | $169.00M | $36.00M | $21.00M |
Net Income | $86.00M | $392.00M | $99.00M | $82.00M |
Net Income Ratio | $0.05 | $0.22 | $0.05 | $0.05 |
EPS | $0.74 | $3.36 | $0.85 | $0.70 |
Diluted EPS | $0.74 | $3.36 | $0.85 | $0.70 |
Weighted Avg Shares Outstanding | $116.22M | $116.50M | $116.47M | $117.14M |
Weighted Avg Shares Outstanding (Diluted) | $116.22M | $116.50M | $116.47M | $117.14M |
The company's financials show resilient growth, with revenue advancing from $1.70B in Q2 2024 to $1.89B in Q1 2025. Gross profit remained healthy with margins at 32% in Q1 2025 compared to 34% in Q2 2024. Operating income hit $181.00M last quarter, sustaining a consistent 10% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $298.00M. Net income dropped to $86.00M, while earnings per share reached $0.74. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan